Construction and validation of a risk prediction model for 3- and 5-year new-onset atrial fibrillation in HFpEF patients

Autor: Shuaishuai Wang, Zhonglei Xie, Fengjiao Wang, Wenzhong Zhang

Publikováno v: Frontiers in Cardiovascular Medicine, Vol 11 (2024)

BackgroundPatients with heart failure (HF) with preserved ejection fraction (HFpEF) are more prone to atrial fibrillation (AF) compared to those with heart failure with reduced ejection fraction (HFrEF). Nevertheless, a risk prediction model for new-

Externí odkaz: https://doaj.org/article/b5ac8440e9cf4edf9efecf8b5548fa7e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement/implantation

Autor: Nso Nso, Kelechi Emmanuel, Mahmoud Nassar, Rubal Bhangal, Sostanie Enoru, Adedapo Iluyomade, Jonathan D. Marmur, Onyedika J. Ilonze, Senthil Thambidorai, Hakeem Ayinde

Publikováno v: International Journal of Cardiology: Heart & Vasculature, Vol 38, Iss, Pp 100910-(2022)

Patients with aortic stenosis who undergo transcatheter aortic valve replacement/transcatheter aortic valve implantation (TAVR/TAVI) experience a high incidence of pre-existing atrial fibrillation (pre-AF) and new-onset atrial fibrillation (NOAF) pos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72f7b2c20830e60de63c6ad9381a5fd
https://pubmed.ncbi.nlm.nih.gov/35146118

Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction

Autor: Mohamed Loutfi, Sherif Wagdy, Mohamed Sobhy

Publikováno v: Clinical Medicine Insights. Cardiology
Clinical Medicine Insights: Cardiology, Vol 10 (2016)
Clinical Medicine Insights: Cardiology, Vol 2016, Iss 10, Pp 19-22 (2016)

Background Neutrophil/lymphocyte (N/L) ratio represents the balance between neutrophil and lymphocyte counts in the body and can be utilized as an index for systemic inflammatory status. The no-reflow phenomenon is defined as inadequate myocardial pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2f8a974392615d0824b800a305f0ed
https://pubmed.ncbi.nlm.nih.gov/26884687

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.